T3P-Y058-739

· T3 Pharmaceuticals AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T3P-Y058-739, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of T3P-Y058-739 (T3P) [Phase 1, Phase 2]